Skip to content
lifestyle.childcarepartnerships.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
Immunovant Inc.
Immunovant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
September 23, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
August 6, 2026
Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026
May 20, 2026
Immunovant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026, and Provide Business Update on Wednesday, May 20, 2026
May 11, 2026
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
April 2, 2026